Promising target for CAR T-cell therapy leads to potent antitumor responses against cutaneous and rare melanomas

UCLA researchers identified the protein TYRP1 as a potential target for CAR T-cell immunotherapy
CAR T cell therapy
A picture of co-culture that shows the CAR T-cell clusters attacking the tumor cells (in green). Image courtesy of the Puig-Saus laboratory.